290
Participants
Start Date
November 30, 2001
Study Completion Date
September 30, 2004
ziprasidone versus olanzapine , risperidone or quetiapine
Panss , CGI-C, UKU-SERS-Pa
Blood tests
Pfizer Investigational Site, Reykjavik
Pfizer Investigational Site, Lausanne
Pfizer Investigational Site, Prangins
Pfizer Investigational Site, Chêne-Bourg
Pfizer Investigational Site, Copenhagen
Pfizer Investigational Site, København S
Pfizer Investigational Site, Glostrup Municipality
Pfizer Investigational Site, Ballerup Municipality
Pfizer Investigational Site, Riehen
Pfizer Investigational Site, Dianalund
Pfizer Investigational Site, Holbæk
Pfizer Investigational Site, Vordingborg
Pfizer Investigational Site, Saint Urban
Pfizer Investigational Site, Odense C
Pfizer Investigational Site, Kolding
Pfizer Investigational Site, Haderslev
Pfizer Investigational Site, Augustenborg
Pfizer Investigational Site, Esbjerg
Pfizer Investigational Site, Esbjerg N
Pfizer Investigational Site, Ringkøbing
Pfizer Investigational Site, Vejle
Pfizer Investigational Site, Lemvig
Pfizer Investigational Site, Arhus C
Pfizer Investigational Site, Zurich
Pfizer Investigational Site, Risskov
Pfizer Investigational Site, Kjellerup
Pfizer Investigational Site, Viborg
Pfizer Investigational Site, Sankt Gallen
Pfizer Investigational Site, Aalborg
Pfizer Investigational Site, Brovst
Pfizer Investigational Site, Turku
Pfizer Investigational Site, Forssa
Pfizer Investigational Site, Mikkeli
Pfizer Investigational Site, Kiviranta
Pfizer Investigational Site, Helsinki
Pfizer Investigational Site, Järvenpää
Pfizer Investigational Site, Tuusula
Pfizer Investigational Site, Basel
Pfizer Investigational Site, Bern
Pfizer Investigational Site, Bulle
Pfizer Investigational Site, Delémont
Pfizer Investigational Site, Oetwil
Pfizer Investigational Site, Solothurn
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY